Molecules 2009, 14(4), 1513-1536; doi:10.3390/molecules14041513
Article

Comparative Molecular Docking of Antitrypanosomal Natural Products into Multiple Trypanosoma brucei Drug Targets

Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA
* Author to whom correspondence should be addressed.
Received: 22 February 2009; in revised form: 7 April 2009 / Accepted: 8 April 2009 / Published: 14 April 2009
PDF Full-text Download PDF Full-Text [1819 KB, uploaded 15 April 2009 08:07 CEST]
Abstract: Antitrypanosomal natural products with different structural motifs previously shown to have growth inhibitory activity against Trypanosoma brucei were docked into validated drug targets of the parasite, which include trypanothione reductase, rhodesain, farnesyl diphosphate synthase, and triosephosphate isomerase. The in-silico calculations predicted that lowest energy docked poses of a number of the compounds can interact with catalysis-dependent residues, thus making them possible catalytic inhibitors and of course physiologically active. Compounds that possess a number of hydrogen-bond-accepting and/or -donating groups like phenolics and quinones show extensive interactions with the targets. Compounds like cissampeloflavone, 3-geranylemodin and ningpogenin thus offer profound promise.
Keywords: Docking; Antitrypanosomal agents; Natural products; Trypanosoma brucei; Protease; Sleeping sickness

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Ogungbe, I.V.; Setzer, W.N. Comparative Molecular Docking of Antitrypanosomal Natural Products into Multiple Trypanosoma brucei Drug Targets. Molecules 2009, 14, 1513-1536.

AMA Style

Ogungbe IV, Setzer WN. Comparative Molecular Docking of Antitrypanosomal Natural Products into Multiple Trypanosoma brucei Drug Targets. Molecules. 2009; 14(4):1513-1536.

Chicago/Turabian Style

Ogungbe, Ifedayo V.; Setzer, William N. 2009. "Comparative Molecular Docking of Antitrypanosomal Natural Products into Multiple Trypanosoma brucei Drug Targets." Molecules 14, no. 4: 1513-1536.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert